81 filings
8-K
ITRM
Iterum Therapeutics Plc
13 May 24
Iterum Therapeutics Reports First Quarter 2024 Financial Results
7:15am
8-K
ITRM
Iterum Therapeutics Plc
10 May 24
Departure of Directors or Certain Officers
4:15pm
8-K
ITRM
Iterum Therapeutics Plc
29 Apr 24
Other Events
4:30pm
8-K
ITRM
Iterum Therapeutics Plc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
ITRM
Iterum Therapeutics Plc
29 Mar 24
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7:15am
8-K
75v8668hftyef
6 Mar 24
Iterum Therapeutics Provides Business Update
8:16am
8-K
uhe1cwd1
30 Jan 24
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
5j1tb7v
30 Jan 24
Regulation FD Disclosure
7:15am
8-K
qmi9jq8ru389o5tb3b
29 Dec 23
Departure of Directors or Certain Officers
4:30pm
8-K
9yzsg
4 Dec 23
Other Events
8:30am
8-K
9kcavv2n 9hm6m2ejsh
14 Nov 23
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
12:00am
8-K
l0e i7xo7xcly
24 Oct 23
Other Events
9:00am
8-K
1k049lqk5ic18zy
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
dwwhkmr9iyw9dhz3 me
11 Aug 23
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
7:15am
8-K
2qnceb7vuj6i4ems
1 Aug 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
16hma
12 May 23
Iterum Therapeutics Reports First Quarter 2023 Financial Results
12:00am
8-K
5f8c wnz41wkjz3ef2l
4 May 23
Material Modifications to Rights of Security Holders
1:26pm
8-K
jjthz40eipl1
16 Mar 23
Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
7:16am
8-K
nbr8k3t ti41
17 Feb 23
Other Events
4:31pm
8-K
thy f7pjj2ry
15 Dec 22
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
4:31pm